May synopsis: The latest in Praxis and clinical research news.

This month’s synopsis includes a breakthrough in identifying the most probable cause of mania-depression cycles, an inside look at how we recruit treatment-naïve patients and how we ensure information security, updates from the Cambridge Healthtech Institute’s conference in Boston, and an interview with Praxis senior analyst Brett Perla on his firsthand experience with clinical trials.

The latest from Praxis.

Recruiting treatment-naïve patients. Find out how social listening, compelling creative, and the right tactics make all the difference when recruiting patients who have yet to undergo treatment for their condition.

Praxis in action on the conference circuit. Our very own Larry Yelton and Bob Loll were in Boston this past month attending Cambridge Healthtech Institute’s seventh annual Clinical Trial Innovation Summit. Read a quick rundown of what took place.

What it’s like to be in a clinical trial. (According to someone who’s actually been in one.) Praxis senior analyst Brett Perla shares his experiences from when he was a teenager taking part in a clinical research study for keratoconus.

Praxis’ focus on the security of patient information. Keeping your data secure and ensuring your privacy are top priorities at Praxis. Learn the steps we take to guarantee patient information security.

Infographic: Recruiting and retaining patients. The data is in. Learn why recruitment and retention are key to successful clinical trials.

May’s pharmaceutical breakthrough: Probable cause of mania-depression cycling identified. In honor of Mental Health Month, read about research leading to the identification of the probable cause of mania-depression cycling in individuals diagnosed with bipolar disorder.

Elsewhere in the news.

A new study conducted at Northwestern University finds that women with early breast cancer may not need chemotherapy. Read about it here:

How many of us would pay $1,000 to keep our stem cells preserved? Read what researchers at Harvard Stem Cell Institute and Stanford University have to say about it:

Physicians have a direct line of contact with potential clinical trial participants. So why don’t we see more patient referrals from physicians?

Stay up-to-date on all the latest from Praxis on our blog, and be sure to check us out on Facebook, Twitter, and LinkedIn.


Any questions? Want to know more?

Contact us today.